title: Idebenone treatment in patients with OPA1-mutant dominant optic atrophy.
authors: Piero
authors: P
authors: Barboni
authors: Maria Lucia
authors: ML
authors: Valentino
authors: Chiara
authors: C
authors: La Morgia
authors: Michele
authors: M
authors: Carbonelli
authors: Giacomo
authors: G
authors: Savini
authors: Annamaria
authors: A
authors: De Negri
authors: Francesca
authors: F
authors: Simonelli
authors: Federico
authors: F
authors: Sadun
authors: Leonardo
authors: L
authors: Caporali
authors: Alessandra
authors: A
authors: Maresca
authors: Rocco
authors: R
authors: Liguori
authors: Agostino
authors: A
authors: Baruzzi
authors: Massimo
authors: M
authors: Zeviani
authors: Valerio
authors: V
authors: Carelli
mesh_terms: D000328:Adult; D002648:Child; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D020558:GTP Phosphohydrolases / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D029241:Optic Atrophy, Autosomal Dominant / Q000188:drug therapy* / Q000235:genetics*; D010865:Pilot Projects; D012189:Retrospective Studies; D016896:Treatment Outcome; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D014792:Visual Acuity / Q000187:drug effects / Q000502:physiology; D055815:Young Adult
chemical_list: D014451:Ubiquinone; D020558:GTP Phosphohydrolases; C415198:OPA1 protein, human; C036619:idebenone